MTE #4: Cardiovascular Risk Assessment in Liver Transplant Candidates (Ticketed)

Nov 16 2024
Convention Center: Room 28 E
7:00 AM - 7:45 AM
Ticketed Event

World Class Speakers

Manhal J Izzy, MD
Discussion Leader

Manhal J Izzy, MD

Vanderbilt University Medical Center
Dempsey L Hughes, MD
Discussion Leader

Dempsey L Hughes, MD

Northwestern University

Description

Experts present information about recent advances in cardiovascular risk assessment and the burden of posttransplant major adverse cardiac events after liver transplant. Topics include the role of nuclear medicine positron emission tomography (NMPET) and computed tomography angiography (CTA) in cardiovascular risk stratification prior to liver transplant, and common cardiovascular complications posttransplant, including management approaches.

Journey Maps

Presentations

6:28 AM - 6:28 AM
Nov 16 2024
San Diego, CA

Role of Traditional Modalities in Cardiovascular Risk Assessment Among Liver Transplant Candidates

Manhal J Izzy, MD, Discussion Leader
Transplant
6:28 AM - 6:28 AM
Nov 16 2024
San Diego, CA

Role of Nontraditional Modalities in Cardiovascular Risk Assessment Among Liver Transplant Candidates

Dempsey L Hughes, MD, Discussion Leader
Transplant

Objectives

  • Review the role of nuclear medicine positron emission tomography (NMPET) and computed tomography angiography (CTA) in risk stratification for liver transplantation.
  • Describe common cardiovascular complications after liver transplant and management of these events.